Noha G Amin

Prof. Dr. Noha G Amin

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2024 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
NANoha G Amin
Noha G Amin
ARA. Abdel Rahim
A. Abdel Rahim
KRKamel Rohoma
Kamel Rohoma
REReham A.ABo Elwafa
Reham A.ABo Elwafa
HDHossam M. F. Dabees
Hossam M. F. Dabees
SEShimaa Elrahmany
Shimaa Elrahmany
Background: Dysregulation of the mechanistic target of rapamycin (mTOR) has been related to several metabolic conditions, notably obesity and type 2 diabetes (T2DM). This study aimed to evaluate the role of mTOR in patients with T2DM, and its relationship with insulin resistance and microvascular complications. Methods: This case-control study was conducted on 90 subjects attending the Outpatient Internal Medicine Clinic in Damanhur Teaching Hospital. Subjects were divided into 3 groups, Group I: 20 healthy controls, Group II: 20 subjects with T2DM without complications, and Group III: 50 subjects with T2DM with microvascular complications. An Enzyme-linked immunosorbent assay was used to measure serum mTOR levels. T2DM and diabetic complications were defined according to the diagnostic criteria of the American Diabetes Association. Results: The results revealed significant positive correlations to HbA1c (r = 0.530, P < 0.001), fasting glucose (r = 0.508, P < 0.001), and HOMA- IR (r = 0.559, P < 0.001), and a significant negative correlation to eGFR (r=-0.370, P = 0.002). Multivariate analysis revealed an independent association of mTOR and HbA1c values with the presence of microvascular complications. The prediction of microvascular complications was present at a cutoff value of 8 ng/ml mTOR with a sensitivity of 100% and specificity of 95% with an AUC of 0.983 and a p-value < 0.001. Conclusion: mTOR is a prognostic marker of diabetic microvascular and is associated with insulin resistance in patients with T2DM. Trial Registration: The study was conducted following the Declaration of Helsinki, and approved by the Ethics Committee of Alexandria University (0201127, 19/7/2018).

10 April 2024 in Clinical Diabetes and Endocrinology
Verified
Journal Article
Open access
PDF file
YGYehia Moustafa Ghanem
Yehia Moustafa Ghanem
YKYasser El Kassar
Yasser El Kassar
MMMay Mohamed Magdy
May Mohamed Magdy
MAMohamed Amara
Mohamed Amara
NANoha G Amin
Noha G Amin
Background: Most of the cases of hyperglycemia during pregnancy are attributed to gestational diabetes mellitus (GDM) (75–90%). Women diagnosed with GDM are at an increased risk for complications during pregnancy and delivery. This observational prospective study aimed to investigate the potential risk of GDM among Egyptian females following in vitro fertilization (IVF) pregnancies compared to spontaneous pregnancies (SC). Methods: This prospective cohort study included normoglycemic females without any history of dysglycemia before this conception. Subjects were divided according to the type of conception into two age and BMI-matched groups: (IVF group): 55 pregnant females conceived by IVF, and (SC group) spontaneous pregnancy: 55 pregnant females conceived spontaneously. A one-step oral glucose tolerance test (OGTT) was performed at gestational weeks 20 and 28 for all study subjects. Results: The incidence of GDM was statistically significantly higher in the IVF group compared to the spontaneous pregnancy (SC) group (20 and 5.5%, respectively), p = 0.022 at week 28. On comparing the incidence of GDM on early screening at week 20 in both groups, the incidence of GDM in the IVF group was significantly higher (16.4%) compared to (3.6%) in the spontaneous pregnancy (SC) group, p = 0.026. Conclusions: IVF may have an increased potential risk for GDM. Moreover, the diagnosis of GDM may occur early (week 20), highlighting the need for precise and early screening for GDM in IVF pregnancies.

12 July 2023 in Alexandria Journal of Medicine
Verified
Journal Article
Open access
MMMagdy Helmy Zikry Megallaa
Magdy Helmy Zikry Megallaa
MSMohamed Said Abdel Salam
Mohamed Said Abdel Salam
NSNeveen Lewis Mikhael Saad
Neveen Lewis Mikhael Saad
MAMohamed Nagy Abdel Hay Ahmed Altair
Mohamed Nagy Abdel Hay Ahmed Altair
NANoha G Amin
Noha G Amin

16 August 2023 in Diabetology International
Verified
Journal Article
Closed access
PDF file
SKSamir H. Assaad Khalil
Samir H. Assaad Khalil
HDHany Mohammed Ali El Deeb
Hany Mohammed Ali El Deeb
MAMartin Otwang Dak Ajang
Martin Otwang Dak Ajang
NONermin A. Osman
Nermin A. Osman
NANoha G Amin
Noha G Amin

7 November 2022 in International Journal of Diabetes in Developing Countries
Verified
Journal Article
Open access
PDF file
HKHeba Sadek Kassab
Heba Sadek Kassab
EMEman Youssif Morsy
Eman Youssif Morsy
AAAbdiwahab Noor Abdirahman
Abdiwahab Noor Abdirahman
NANoha G Amin
Noha G Amin
Purpose: Diabetic retinopathy (DR) is a major preventable health complication of type 2 diabetes (T2DM). Hyperglycemia represents the main mechanism in the pathogenesis of DR leading eventually to endothelial dysfunction. vWF is a marker of endothelial dysfunction, but its relation to DR is not yet well-established. Methods: The present study included 60 patients with T2DM divided into three equal groups according to the presence and the stage of retinopathy. Each patient was subjected to full history taking, physical examination including fundus examination, and laboratory investigations including glycemic and lipid profile, urinary albumin to creatinine ratio (UACR), and plasma vWF level. Results: Plasma vWF was significantly higher in patients with DR than in patients without retinopathy. vWF was positively correlated to age, HbA1c, diabetes duration, and UACR in DR groups and the total sample. Univariate regression analysis revealed that HbA1c, vWF, BMI, diabetes duration, and UACR were independent risk factors for DR, while multivariate regression analysis showed none of them to be an independent risk factor for DR. A vWF cut-off value of > 180 could differentiate patients with DR from patients without DR with a sensitivity of 97.5%, specificity of 75%, and AUC 0.937*. Conclusions: vWF level is higher in patients with DR reflecting the role of endothelial dysfunction in the development of DR. Moreover, it is one of the risk factors affecting DR in univariate but not in multivariate analysis. A cut-off value of vWF level was set to differentiate between patients with and without DR.

1 June 2022 in ALEXMED ePosters
Verified
Journal Article
Open access
MBMohamed Ali El Bahrawy
Mohamed Ali El Bahrawy
NANoha G Amin
Noha G Amin
YIYasmine Issa
Yasmine Issa
TGThoryia Mohamed Said Ghazy
Thoryia Mohamed Said Ghazy
Diabetic nephropathy (DN) occurs in 40% of patients with diabetes mellitus (DM) diagnosed clinically by presence of albuminuria andor reduced eGFR in the absence of signs and symptoms of other primary cause of renal damage.Since serum creatinine concentration not depends only on GFR but many additional factors such as muscle mass, sex, age, diet and pharmacological treatment. So, we in need for novel biomarker of decreased GFR without increased albuminuria before the kidneys are irreversibly damaged.Serum osteoinductive factor (OIF) belong to small leucine rich repeat proteoglycans (SLRP)family and it is a secretory protein.Recent studies suggest that OIF may play a direct role in DN through the development of renal fibrosis and atherosclerosis of renal arteries.Aim of the work:Our study aimed to asses serum OIF as a marker of early DN in patient with type 2 DM and its correlation with albuminuria and eGFR in different stages of the disease.